Number of shares and voting rights as at 31 December 2015


Number of shares and voting rights

Article L.233-8-II of Commercial Law (Code de commerce) and

Article 223-16 of the General Regulation of the French Financial Markets Authority

(AMF - Autorité des Marchés Financiers)


Press release

Avignon, January 11th, 2016


 



31.12.2015



 





Total number of outstanding shares forming the capital

- 9,236,634 ordinary shares under ISIN FR0000054694

- 2,216 shares issued from stock-options under ISIN FR0000054694
 

9,238,850


Number of shares with double voting rights
2,099,773


Total number of gross voting rights
11,338,623


Number of shares without voting rights

- 4,488 bearer shares in the frame of the liquidity contract 
 

- 4,488


Total number of exercisable voting rights*
11,334,135


*Exercisable voting rights = total number of voting rights - number of shares without voting rights


 


 


You can receive all financial information of Naturex free of charge by signing up at: www.naturex.com



Financial schedule




Revenue - FY 2015
04 February 2016


Results - FY 2015
30 March 2016




Upcoming events




SFAF Analysts Meeting
31 March 2016


General Meeting
21 June 2016



 


Naturex has been listed since October 1996 on Euronext in Paris, Segment B






Total number of shares comprising the share capital: 9,238,850 (December 2015)

ISIN FR0000054694



Naturex is a component of the CACT, Enternext CAC PEA-PME 150, CAC Small & Mid, CAC Small, Gaïa Index.

Naturex is eligible for the "long only" Deferred Settlement Service (SRD) and French equity plans (PEA and PEA-PME).

Naturex established a Sponsored Level 1 American Depositary Receipt (ADR) program in the United States. Under this facility, Naturex's ADRs are traded over-the-counter in the United States under the symbol NTUXY.



TICKER: NRX - Reuters: NATU.PA - Bloomberg: NRX:FP - DR SYMBOL: NTUXY


About Naturex


Naturex is the global leader in speciality plant-based natural ingredients. The Group is organised around three strategic markets (Food & Beverage, Nutrition & Health and Personal Care) and produces and markets speciality plant-based ingredients for the food, nutraceutical, pharmaceutical and cosmetic industries.


Naturex's head office is based in Avignon. The company employs 1,700 people with 8 sourcing offices located throughout the world and high-performance manufacturing operations across 15 sites in Europe, Morocco, the United States, Brazil, Australia and India. It also has a global commercial presence through a dedicated network of sales offices in more than 20 countries.



Contacts



Carole Alexandre

Investor Relations

Tel.: +33 (0)4 90 23 78 28

c.alexandre@naturex.com
Anne Catherine Bonjour

Actus Finance Press Relations

Tel.: +33 (0)1 53 67 36 93

acbonjour@actus.fr

Information réglementée
Information relative au nombre total de droits de vote et d'actions composant le capital :

-
Full and original press release in PDF:


http://www.actusnews.com/documents_communiques/ACTUS-0-42707-cp-naturex_110116.pdf

© Copyright Actusnews Wire

Recevez gratuitement par email les prochains communiqués de la société en vous inscrivant sur www.actusnews.com

Receive by email the next press releases of the company by registering on www.actusnews.com, it's free



Quelle: Actusnews